‘Innovation’ is often used as a shorthand for improved technical, economic and social processes. However, any specific innovation involves the redistribution of costs and benefits, creating winners and losers. For some, regulation of technology should be avoided in case it hinders innovation, while, for others, regulation is an essential measure to mitigate risks. However, regulation and innovation are not a zero-sum game. Debates about regulatory (in)action and its impact on innovation would benefit from greater specificity about which innovation paths are considered desirable, for whom, and how policy choices would help to achieve them.

EPRS STOA podcast - What if AI regulation promoted innovation?

Sequencing and analysis of the human genome, all the genetic information stored in our DNA, enable understanding about a person’s ancestry, health and various traits. DNA sequencing greatly benefits medicine and the life sciences by allowing them to predict and cure diseases. While DNA sequencing technologies continuously improve and become less costly, what if we all soon possessed our personal, smart DNA sequencers and apps to analyse DNA?

EPRS podcast - STOA: What if consumers could use devices to sequence DNA?

An efficient and modern public system is a pre-condition for smart societies and economies. But how do we foster public sector innovation? The EU doesn’t have a direct role here, but it can definitely provide direction! So, stay with us… as we spell out a new vision for the public sector in Europe!

EPRS policy podcast - Public sector innovation: Concepts, trends and best practices

Horizon Europe is the framework programme for research and innovation.

In the 2021-2027 period, Horizon Europe will have a total budget allocation of of €95.517 billion (in current prices), which equals €84.9 billion (in constant 2018 prices). Horizon Europe will be implemented through three pillars: the Open Science pillar; the Global Challenges and Industrial Competitiveness pillar; and the Open Innovation pillar. The main aims are to strengthen science and technology, to foster industrial competiveness, and to implement the sustainable development goals in the EU.

The Covid-19 pandemic has demonstrated that research and innovation are drivers for economic recovery. Hundreds of millions of euros have been mobilised in coronavirus research projects under the previous EU funding programme, Horizon 2020. The new programme will continue to support health research and help the EU´s health systems to prepare for future crises.

Horizon Europe

Opening address at the European Research and Innovation Days by Roberta METSOLA, EP President

EP Plenary session - Global approach to research and innovation: Europe’s strategy for international cooperation in a changing world - O.Q.

EP Plenary session - Joint debate - Research and Innovation

6th Management Innovation Day - Resilience : Managing the crisis after the crisis.- Closing remarks

6th Management Innovation Day - Resilience : Managing the crisis after the crisis.- Where next for Transatlantic relations ?

6th Management Innovation Day - Resilience : Managing the crisis after the crisis.- Building a more resilient Europe in an uncertain world

6th Management Innovation Day - Resilience : Managing the crisis after the crisis.- Building a more resilient Europe in an uncertain world .

6th Management Innovation Day - Resilience : Managing the crisis after the crisis.- Opening session

EP Press conference. Horizon Europe

High Level Conference - ' EU Research and Innovation in our daily life '

High Level Conference - ' EU Research and Innovation in our daily life 'Exhibition

High Level Conference - ' EU Research and Innovation in our daily life '- A sustainable environment

High Level Conference - ' EU Research and Innovation in our daily life '- Press conference

Following the join press point of Cristian-Silviu BUŞOI (EPP, RO), Chair of ITRE and Sabine VERHEYEN (EPP, DE), Chair of CULT, Iliana IVANOVA, Commissionner-designate for innovation, research, culture, education and youth, gives a statement. Whenever a member of the European Commission needs to be replaced or there is a significant reassignment of portfolios, Parliament invites the candidates for the new jobs to hearings so that MEPs can evaluate them. Ivanova would be responsible for innovation, research, culture, education and youth, replacing Mariya Gabriel who stepped down in May 2023 to take up a post in the new Bulgarian government. The transcript is the result of an automated process. Please check against delivery.

Statement by Iliana IVANOVA, Commissionner-designate for innovation, research, culture, education and youth

The Committees on Industry, Research and Energy (ITRE) and the Committee on Culture and Education (CULT) hold a joint public hearing with Ms Iliana IVANOVA, Commissioner-designate for innovation, research, culture, education and youth. Ivanova has been named by the Bulgarian Government to substitute the former Commissioner Maryia Gabriel who left the office on the 15th of may 2023. Closure by Cristian-Silviu BUŞOI (EPP, RO), Chair of ITRE and Sabine VERHEYEN (EPP, DE), Chair of CULT.

Hearing of Iliana IVANOVA, Commissioner-designate for innovation, research, culture, education and youth: closure by Cristian-Silviu BUŞOI (EPP, RO), Chair of ITRE and Sabine VERHEYEN (EPP, DE), Chair of CULT

The Committees on Industry, Research and Energy (ITRE) and the Committee on Culture and Education (CULT) hold a joint public hearing with Ms Iliana IVANOVA, Commissioner-designate for innovation, research, culture, education and youth. Ivanova has been named by the Bulgarian Government to substitute the former Commissioner Maryia Gabriel who left the office on the 15th of may 2023. Concluding remarks by Iliana IVANOVA, Commissioner-designate for innovation, research, culture, education and youth.

Hearing of Iliana IVANOVA, Commissioner-designate for innovation, research, culture, education and youth: closing statements

The Committees on Industry, Research and Energy (ITRE) and the Committee on Culture and Education (CULT) hold a joint public hearing with Ms Iliana IVANOVA, Commissioner-designate for innovation, research, culture, education and youth. Ivanova has been named by the Bulgarian Government to substitute the former Commissioner Maryia Gabriel who left the office on the 15th of may 2023. Third part of the questions and answers session with the MEPs.

Hearing of Iliana IVANOVA, Commissioner-designate for innovation, research, culture, education and youth: questions and answers (part 3)

The Committees on Industry, Research and Energy (ITRE) and the Committee on Culture and Education (CULT) hold a joint public hearing with Ms Iliana IVANOVA, Commissioner-designate for innovation, research, culture, education and youth. Ivanova has been named by the Bulgarian Government to substitute the former Commissioner Maryia Gabriel who left the office on the 15th of may 2023. Second part of the questions and answers session with the MEPs.

Hearing of Iliana IVANOVA, Commissioner-designate for innovation, research, culture, education and youth: questions and answers (part 2)

The Committees on Industry, Research and Energy (ITRE) and the Committee on Culture and Education (CULT) hold a joint public hearing with Ms Iliana IVANOVA, Commissioner-designate for innovation, research, culture, education and youth. Ivanova has been named by the Bulgarian Government to substitute the former Commissioner Maryia Gabriel who left the office on the 15th of may 2023. First part of the questions and answers session with the MEPs.

Hearing of Iliana IVANOVA, Commissioner-designate for innovation, research, culture, education and youth: questions and answers (part 1)

Iliana IVANOVA, Commissioner candidate gives her opening statement during the Committees on Industry, Research and Energy (ITRE) and the Committee on Culture and Education (CULT) joint public hearing. Ivanova has been named by the Bulgarian Government to substitute the former Commissioner Maryia Gabriel, who left the office on the 15th of may 2023, as Commissioner for innovation, research, culture, education and youth. Opening statement by Iliana IVANOVA, Commissioner candidate. The transcript is the result of an automated process. Please check against delivery.

Hearing of Iliana IVANOVA, Commissioner-designate for innovation, research, culture, education and youth: opening statement by Iliana IVANOVA, Commissioner candidate

Cristian-Silviu BUŞOI (EPP, RO), Chair of ITRE and Sabine VERHEYEN (EPP, DE), Chair of CULT give their opening statements during the joint public hearing with Ms Iliana IVANOVA, Commissioner-designate for innovation, research, culture, education and youth. Ivanova has been named by the Bulgarian Government to substitute the former Commissioner Maryia Gabriel who left the office on the 15th of may 2023. Opening and introduction by Cristian-Silviu BUŞOI (EPP, RO), Chair of ITRE and Sabine VERHEYEN (EPP, DE), Chair of CULT. The transcript is the result of an automated process. Please check against delivery.

Hearing of Iliana IVANOVA, Commissioner-designate for innovation, research, culture, education and youth: opening statements by Cristian-Silviu BUŞOI (EPP, RO), Chair of ITRE and Sabine VERHEYEN (EPP, DE), Chair of CULT

The Committee on Industry, Research and Energy (ITRE) and the Committee on Culture and Education (CULT) hold a joint public hearing with Ms Iliana IVANOVA, Commissioner-designate for innovation, research, culture, education and youth. Ivanova has been named by the Bulgarian Government to substitute the former Commissioner Maryia Gabriel who left the office on the 15th of may 2023. Arrivals and ambiance shots.

Hearing of Iliana IVANOVA, Commissioner-designate for innovation, research, culture, education and youth: arrivals and ambiance shots

Many rare diseases manifest themselves in childhood, resulting in a shortened lifespan and leading to a dependency on care throughout the patients’ lives, causing significant suffering to the patients and their families. Patients affected by rare diseases often spend years enduring a “diagnostic odyssey” before receiving the correct diagnosis, if ever. Most rare diseases lack effective treatments representing an enormous unmet medical need. EU research and innovation is crucial to accelerate the discovery and development of novel therapeutics. Restrictions: ©The material may not be edited and must be shown entirely.

EPRS - 5 facts about rare diseases

During the plenary session (26-29 April 2021) in the European Parliament in Brussels, MEPs debate on research and innovation. Opening statements by the rapporteurs Marc BOTENGA - Establishing Horizon Europe – laying down its rules for participation and dissemination; Christian EHLER (EPP, DE) - Specific Programme implementing Horizon Europe – the Framework Programme for Research and Innovation; Marisa MATIAS (The Left, PT) - European Institute of Innovation and Technology; Maria da Graça CARVALHO (EPP, PT) - Strategic Innovation Agenda of the European Institute of Innovation and Technology; and by Mariya GABRIEL, European Commissioner for Innovation, Research, Culture, Education and Youth. This transcription speech is the result of an automatic process. Check against delivery.

Joint debate on research and innovation: opening statements by the rapporteurs and by Mariya GABRIEL, European Commissioner for Innovation, Research, Culture, Education and Youth

During the plenary session (26-29 April 2021) in the European Parliament in Brussels, MEPs debate on research and innovation.

Joint debate - Research and Innovation: MEPs debate

During the plenary session (26-29 April 2021) in the European Parliament in Brussels, closing statement by Mariya GABRIEL, European Commissioner for Innovation, Research, Culture, Education and Youth.

Joint debate - Research and Innovation: closing statement by Mariya GABRIEL, European Commissioner for Innovation, Research, Culture, Education and Youth

Cancer research, and its translation into everyday clinical practice, is fundamental to ensuring continual improvements in cancer prevention, diagnosis, treatment and follow-up care for survivors. The needs of basic cancer research must achieve a high profile with the EU Cancer Mission and Horizon Europe research and innovation programme in order to maintain Europe's position at the forefront of discovery and breakthrough in understanding cancer. This infoclip shows how scientists work on studies to find better ways to prevent and treat cancer. ICANS | Strasbourg Europe Cancer Institute combines the Paul Strauss Center, one of the Comprehensive Cancer Centers in France, and the University Hospital of Strasbourg oncology teams. This institute is entirely dedicated to patients and works in three different areas: cares teaching and research.

Infoclip: Europe's Beating Cancer Plan - Research

This stockshot provides images of two Belgian FabLabs, Trakk and Makilab, finding innovative solutions to compensate the lack of medical equipment by using 3D printing.

Infoclip: Covid-19 - Belgian FabLabs

Dan NICA (S&D, RO), and Christian EHLER (EPP, DE), rapporteurs, speak the press on Horizon Europe during a press conference in Strasbourg.

Press conference by Dan NICA (S&D, RO), and Christian EHLER (EPP, DE), rapporteurs, on Horizon Europe

Christian EHLER (EPP, DE) and Dan NICA (S&D, RO), rapporteurs, on Horizon Europe in the European Parliament in Brussels.

Press conference by Christian EHLER (EPP, DE) and Dan NICA (S&D, RO), rapporteurs, on Horizon Europe

Antonio TAJANI, EP President, participates in the joint conference titled 'EU Research and Innovation in our daily life'. The event, which brings together researchers and politicians to reflect on past and present achievements and talk about the challenges ahead, takes place in the European Parliament in Brussels and focuses on how the 200 billion euros invested over the past 30 years have affected citizens' daily life.

26 résultats